8-K Announcements
6Material company update
Apr 21, 2026·SEC
Material company update
Jan 26, 2026·SEC
Material company update
Dec 5, 2025·SEC
W. R. Berkley Corporation(WRB)Earnings, Financials & Key Ratios
WRB•NYSE•Insurance & Managed Care
$66.52
$24.91B mkt cap·14.9× P/E·Price updated May 7, 2026
SectorFinancial ServicesIndustryProperty & Casualty InsuranceSub-IndustryCommercial lines and surety insurers
AboutW. R. Berkley Corporation, an insurance holding company, operates as a commercial lines writer in the United States and internationally. It operates in two segments, Insurance and Reinsurance & Monoline Excess. The Insurance segment underwrites commercial insurance business, including premises operations, commercial automobile, property, products liability, and general and professional liability lines. It also provides workers' compensation insurance products; accident and health insurance and reinsurance products; insurance for commercial risks; specialty environmental products for contractors, consultants, and property owners and facilities operators; specialized insurance coverages for fine arts and jewelry exposures; umbrella and excess liability coverage products; and liquor liability and inland marine coverage for small to medium-sized insureds. In addition, this segment offers directors and officers, and surety risk products, as well as products for technology, and life sciences and travel industries; cyber risk solutions; casualty, group life, and crime and fidelity related insurance products; personal lines insurance solutions, including home, condo/co-op, auto, and collectibles; automobile, law enforcement, public officials and educator's legal, and employment practices liability, as well as incidental medical insurance products; and at-risk and alternative risk insurance program management services. The Reinsurance & Monoline Excess segment provides other insurance companies and self-insureds with assistance in managing their net risk through reinsurance on a portfolio basis through treaty reinsurance or on an individual basis through facultative reinsurance. W. R. Berkley Corporation was founded in 1967 and is based in Greenwich, Connecticut.Show more
- Revenue$14.71B+7.8%
- Combined Ratio84.13%+0.9%
- Net Income$1.78B+1.3%
- Return on Equity19.64%-11.2%
- Medical Cost Ratio80.19%+4.0%
- Operating Margin15.87%-4.4%
- Net Margin12.1%-6.0%
- ROA4.2%-6.9%
- Equity / Assets22.04%+6.3%
- Book Value per Share24.33+16.7%
- Tangible BV/Share21.36+18.5%
- Debt/Equity0.29-13.5%
WRB Key Insights
W. R. Berkley Corporation (WRB) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Profitable underwriting: 84.1% combined ratio
- ✓Excellent 3Y average ROE of 20.4%
- ✓Strong 5Y profit CAGR of 27.4%
- ✓Healthy dividend yield of 2.6%
✗Weaknesses
- ✗High loss ratio of 80.2%
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
WRB Price & Volume
W. R. Berkley Corporation (WRB) stock price & volume — 10-year historical chart
Loading chart...
WRB Growth Metrics
W. R. Berkley Corporation (WRB) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years7.39%
5 Years12.67%
3 Years9.61%
TTM7.82%
Profit CAGR
10 Years13.45%
5 Years27.38%
3 Years8.81%
TTM1.33%
EPS CAGR
10 Years14.49%
5 Years28.91%
3 Years10.59%
TTM2.06%
Return on Capital
10 Years8.02%
5 Years12.77%
3 Years13.57%
Last Year13.86%
WRB Recent Earnings
W. R. Berkley Corporation (WRB) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
Apr 21, 2026EPS
$1.30
Est $1.13
+15.0%
Revenue
$3.1B
Est $3.2B
-2.4%
Q1 2026
Jan 26, 2026EPS
$1.13
Est $1.13
+0.0%
Revenue
$3.2B
Est $3.1B
+1.1%
Q4 2025
Oct 20, 2025EPS
$1.10
Est $1.11
-0.9%
Revenue
$3.8B
Est $3.2B
+19.5%
Q3 2025
Jul 21, 2025EPS
$1.05
Est $1.03
+1.9%
Revenue
$3.7B
Est $3.1B
+18.4%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 21, 2026 | $1.30vs $1.13+15.0% | $3.1Bvs $3.2B-2.4% |
| Q1 2026 | Jan 26, 2026 | $1.13vs $1.13+0.0% | $3.2Bvs $3.1B+1.1% |
| Q4 2025 | Oct 20, 2025 | $1.10vs $1.11-0.9% | $3.8Bvs $3.2B+19.5% |
| Q3 2025 | Jul 21, 2025 | $1.05vs $1.03+1.9% | $3.7Bvs $3.1B+18.4% |
Based on last 12 quarters of dataView full earnings history →
WRB Peer Comparison
W. R. Berkley Corporation (WRB) competitors in Commercial lines and surety insurers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HIG | 36.49B | 132.67 | 9.96 | 7.1% | 14.13% | 22.01% | 0.23 | |
 CNA | 11.82B | 43.69 | 9.32 | 5.1% | 8.95% | 11.94% | 0.26 | |
 MKL | 22.52B | 1799.97 | 10.64 | -0.96% | 10.7% | 9.56% | 0.23 | |
 RLI | 4.56B | 49.62 | 11.38 | 6.33% | 20.8% | 22% | 0.06 | |
 ACGL | 33.67B | 94.52 | 8.13 | 14.27% | 22.07% | 19.02% | 0.11 | |
 WTM | 5.19B | 2093.98 | 4.87 | 14.99% | 41.78% | 22.17% | 0.13 | |
 AIG | 41.01B | 76.43 | 14.08 | -1.82% | 11.86% | 7.7% | 0.22 | |
 TRV | 64.62B | 298.86 | 10.90 | 5.17% | 12.88% | 19.12% | 0.28 |
Compare WRB vs Peers
W. R. Berkley Corporation (WRB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
WRB Income Statement
W. R. Berkley Corporation (WRB) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.01B | 7.69B | 7.9B | 8.1B | 9.46B | 11.17B | 12.14B | 13.64B | 14.71B |
| Revenue Growth % | 4.66% | -3.99% | 2.74% | 2.49% | 16.75% | 18.1% | 8.74% | 12.32% | 7.82% |
| Medical Costs & Claims | 6.36B | 6.31B | 6.42B | 6.75B | 7.43B | 8.73B | 9.42B | 10.52B | 11.79B |
| Medical Cost Ratio % | 79.43% | 82.04% | 81.29% | 83.36% | 78.61% | 78.17% | 77.56% | 77.11% | 80.19% |
| Gross Profit | 1.65B▲ 0% | 1.38B▼ 16.2% | 1.48B▲ 7.0% | 1.35B▼ 8.8% | 2.02B▲ 50.1% | 2.44B▲ 20.5% | 2.72B▲ 11.7% | 3.12B▲ 14.6% | 2.91B▼ 6.7% |
| Gross Margin % | 20.57% | 17.96% | 18.71% | 16.64% | 21.39% | 21.83% | 22.44% | 22.89% | 19.81% |
| Gross Profit Growth % | 14.34% | -16.18% | 7.01% | -8.82% | 50.08% | 20.53% | 11.75% | 14.58% | -6.66% |
| Operating Expenses | 875.24M | 569.26M | 625.23M | 642.96M | 739.87M | 718.33M | 969.99M | 857.12M | 579.43M |
| OpEx / Revenue % | 10.93% | 7.4% | 7.91% | 7.94% | 7.82% | 6.43% | 7.99% | 6.28% | 3.94% |
| Depreciation & Amortization | 112.96M | 131.11M | 113.39M | 135.06M | 129.68M | 55.87M | -20.86M | -170.64M | -32.82M |
| Combined Ratio % | 90.35% | 89.44% | 89.21% | 91.3% | 86.43% | 84.6% | 85.55% | 83.4% | 84.13% |
| Operating Income | 772.77M▲ 0% | 812.09M▲ 5.1% | 852.92M▲ 5.0% | 704.8M▼ 17.4% | 1.28B▲ 82.0% | 1.72B▲ 34.0% | 1.75B▲ 2.0% | 2.26B▲ 29.1% | 2.33B▲ 3.1% |
| Operating Margin % | 9.65% | 10.56% | 10.79% | 8.7% | 13.57% | 15.4% | 14.45% | 16.6% | 15.87% |
| Operating Income Growth % | -13.8% | 5.09% | 5.03% | -17.37% | 82.02% | 34.05% | 2.02% | 29.07% | 3.08% |
| EBITDA | 885.73M | 943.2M | 966.31M | 839.87M | 1.41B | 1.78B | 1.73B | 2.09B | 2.3B |
| EBITDA Margin % | 11.06% | 12.26% | 12.23% | 10.37% | 14.94% | 15.9% | 14.28% | 15.35% | 15.65% |
| Interest Expense | 147.3M | 157.19M | 153.41M | 150.54M | 147.18M | 130.37M | 127.46M | 126.91M | 126.89M |
| Non-Operating Income | -147.3M | -157.19M | -153.41M | -150.54M | -147.18M | -130.37M | -127.46M | -126.91M | -70.74M |
| Pretax Income | 772.77M▲ 0% | 812.09M▲ 5.1% | 852.92M▲ 5.0% | 704.8M▼ 17.4% | 1.28B▲ 82.0% | 1.72B▲ 34.0% | 1.75B▲ 2.0% | 2.26B▲ 29.1% | 2.28B▲ 0.7% |
| Pretax Margin % | 9.65% | 10.56% | 10.79% | 8.7% | 13.57% | 15.4% | 14.45% | 16.6% | 15.51% |
| Income Tax | 219.43M | 163.03M | 168.94M | 171.82M | 251.89M | 334.73M | 370.56M | 509.92M | 495.77M |
| Effective Tax Rate % | 28.4% | 20.08% | 19.81% | 24.38% | 19.63% | 19.46% | 21.12% | 22.52% | 21.74% |
| Net Income | 549.09M▲ 0% | 640.75M▲ 16.7% | 681.94M▲ 6.4% | 530.67M▼ 22.2% | 1.02B▲ 92.7% | 1.38B▲ 35.1% | 1.38B▲ 0.0% | 1.76B▲ 27.1% | 1.78B▲ 1.3% |
| Net Margin % | 6.85% | 8.33% | 8.63% | 6.55% | 10.81% | 12.37% | 11.38% | 12.88% | 12.1% |
| Net Income Growth % | -8.78% | 16.69% | 6.43% | -22.18% | 92.68% | 35.07% | 0.02% | 27.13% | 1.33% |
| EPS (Diluted) | 1.26▲ 0% | 1.48▲ 17.5% | 1.56▲ 5.4% | 1.25▼ 19.9% | 2.44▲ 95.2% | 3.29▲ 34.8% | 3.37▲ 2.4% | 4.36▲ 29.4% | 4.45▲ 2.1% |
| EPS Growth % | -9.35% | 17.46% | 5.41% | -19.87% | 95.2% | 34.84% | 2.43% | 29.38% | 2.06% |
| EPS (Basic) | 1.30 | 1.48 | 1.59 | 1.26 | 2.46 | 3.33 | 3.40 | 4.39 | 4.48 |
| Diluted Shares Outstanding | 435.44M | 432.89M | 435.42M | 424.72M | 419.62M | 419.19M | 409.95M | 403.22M | 399.13M |
WRB Balance Sheet
W. R. Berkley Corporation (WRB) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 24.3B | 24.9B | 26.66B | 28.61B | 32.09B | 33.86B | 37.2B | 40.57B | 44.07B |
| Asset Growth % | 4% | 2.45% | 7.09% | 7.29% | 12.16% | 5.53% | 9.87% | 9.05% | 8.64% |
| Total Investment Assets | 17.45B | 17.72B | 18.47B | 18.48B | 22.17B | 22.86B | 25.28B | 27.89B | 30.69B |
| Long-Term Investments | 15.9B | 15.67B | 16.28B | 16.44B | 4.39B | 4.38B | 4.22B | 4.41B | 4.45B |
| Short-Term Investments | 14.13B | 13.61B | 14.18B | 14.16B | 17.78B | 18.48B | 21.06B | 23.48B | 26.24B |
| Total Current Assets | 0 | 0 | 0 | 0 | 25.62B | 27.03B | 30.35B | 33.44B | 36.89B |
| Cash & Equivalents | 950.47M | 817.6M | 1.02B | 2.37B | 1.57B | 1.45B | 1.36B | 1.97B | 2.54B |
| Receivables | 3.75B | 4.09B | 4.58B | 5.12B | 5.59B | 6.41B | 7.16B | 7.17B | 7.23B |
| Other Current Assets | -19.3B | -19.01B | -20.35B | -22.3B | 0 | 0 | 0 | 0 | 0 |
| Goodwill & Intangibles | 178.94M | 173.04M | 169.65M | 169.65M | 845.8M | 949M | 1.04B | 1.14B | 1.19B |
| Goodwill | 178.94M | 173.04M | 169.65M | 169.65M | 169.65M | 185.51M | 174.6M | 184.33M | 184.33M |
| Intangible Assets | 0 | 0 | 0 | 0 | 676.14M | 763.49M | 861.61M | 951.73M | 1B |
| PP&E (Net) | 422.96M | 416.37M | 422.09M | 405.93M | 419.88M | 423.23M | 426.8M | 478.51M | 596.24M |
| Other Assets | -16.5B | -16.26B | -16.87B | -17.01B | 753.23M | 736.02M | 865.56M | 877.1M | 809.39M |
| Total Liabilities | 18.85B | 19.42B | 20.54B | 22.28B | 25.42B | 27.09B | 29.73B | 32.16B | 34.36B |
| Total Debt | 2.5B | 2.79B | 2.63B | 2.73B | 3.27B | 2.84B | 2.84B | 2.84B | 2.84B |
| Net Debt | 1.55B | 1.97B | 1.6B | 352.97M | 1.7B | 1.39B | 1.48B | 866.22M | 299.79M |
| Long-Term Debt | 2.5B | 2.79B | 2.63B | 2.73B | 3.27B | 2.83B | 2.84B | 2.84B | 2.84B |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 5.4M | 5.4M | 0 | 0 |
| Total Current Liabilities | 0 | 0 | 0 | 0 | 18.3B | 20.12B | 22.32B | 24.4B | 26.54B |
| Accounts Payable | 246.46M | 256.92M | 360.31M | 426.12M | 568.62M | 523.13M | 631.16M | 668.65M | 615.78M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 4.85B | 5.3B | 5.92B | 6.38B | 6.72B |
| Other Current Liabilities | -257.79M | -256.92M | -370.32M | -467.41M | 12.87B | 14.26B | 15.7B | 17.23B | 19.05B |
| Deferred Taxes | 1000K | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Liabilities | -2.58B | -2.79B | -2.65B | -2.77B | 3.83B | 4.13B | 4.53B | 4.85B | 4.88B |
| Total Equity | 5.45B▲ 0% | 5.48B▲ 0.5% | 6.12B▲ 11.7% | 6.33B▲ 3.4% | 6.67B▲ 5.4% | 6.77B▲ 1.5% | 7.47B▲ 10.4% | 8.41B▲ 12.6% | 9.71B▲ 15.5% |
| Equity Growth % | 7.28% | 0.53% | 11.65% | 3.39% | 5.41% | 1.51% | 10.36% | 12.56% | 15.52% |
| Shareholders Equity | 5.41B | 5.44B | 6.07B | 6.31B | 6.65B | 6.75B | 7.46B | 8.4B | 9.7B |
| Minority Interest | 39.82M | 41.95M | 43.4M | 14.99M | 14.72M | 19.83M | 13.81M | 12.33M | 11.08M |
| Retained Earnings | 6.96B | 7.56B | 7.93B | 8.35B | 9.02B | 10.16B | 11.04B | 12.27B | 13.34B |
| Common Stock | 47.02M | 70.53M | 70.53M | 70.53M | 105.8M | 105.8M | 158.71M | 158.71M | 158.71M |
| Accumulated OCI | 68.54M | -510.47M | -257.3M | -62.17M | -281.95M | -1.26B | -925.84M | -934.27M | -451.1M |
| Return on Equity (ROE) | 10.43% | 11.72% | 11.76% | 8.53% | 15.74% | 20.56% | 19.4% | 22.12% | 19.64% |
| Return on Assets (ROA) | 2.3% | 2.6% | 2.65% | 1.92% | 3.37% | 4.19% | 3.89% | 4.52% | 4.2% |
| Equity / Assets | 22.43% | 22.01% | 22.95% | 22.11% | 20.78% | 19.99% | 20.08% | 20.72% | 22.04% |
| Debt / Equity | 0.46x | 0.51x | 0.43x | 0.43x | 0.49x | 0.42x | 0.38x | 0.34x | 0.29x |
| Book Value per Share | 12.52 | 12.66 | 14.05 | 14.89 | 15.89 | 16.15 | 18.22 | 20.85 | 24.33 |
| Tangible BV per Share | 12.11 | 12.26 | 13.66 | 14.49 | 13.87 | 13.88 | 15.69 | 18.03 | 21.36 |
WRB Cash Flow Statement
W. R. Berkley Corporation (WRB) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 710.88M | 620.2M | 1.14B | 1.62B | 2.18B | 2.57B | 2.93B | 3.68B | 3.64B |
| Operating CF Growth % | -16.21% | -12.76% | 84.42% | 41.34% | 35.09% | 17.61% | 14.04% | 25.57% | -1.06% |
| Operating CF / Revenue % | 8.87% | 8.06% | 14.47% | 19.96% | 23.1% | 23% | 24.12% | 26.97% | 24.75% |
| Net Income | 549.09M | 640.75M | 681.94M | 530.67M | 1.02B | 1.38B | 1.38B | 1.76B | 1.78B |
| Depreciation & Amortization | 112.96M | 131.11M | 113.39M | 135.06M | 129.68M | 55.87M | -20.86M | -170.64M | -48.13M |
| Stock-Based Compensation | 40.49M | 36.59M | 49.27M | 49.66M | 46.68M | 49.41M | 51M | 54.38M | 0 |
| Deferred Taxes | -16.89M | -74.76M | -189.9M | -157.25M | -310.65M | -64.71M | 0 | 0 | 0 |
| Other Non-Cash Items | -384.06M | -180.76M | 2.04M | 2.31M | 8.53M | -278.89M | -115.51M | -107.75M | -99.9M |
| Working Capital Changes | 409.29M | 67.27M | 487.04M | 1.06B | 1.29B | 1.43B | 1.63B | 2.15B | 2.01B |
| Cash from Investing | -333.46M | -714.24M | -424.87M | 119.7M | -2.99B | -1.89B | -1.96B | -2.18B | -2.03B |
| Capital Expenditures | -115.72M | -49.86M | -60.46M | -38.17M | -66.63M | -52.68M | -53.08M | -105.62M | -169.99M |
| Acquisitions | -70.57M | 2.03M | 51.39M | 180.4M | 240.51M | 857.22M | -11.56M | 0 | 0 |
| Purchase of Investments | -7.97B | -6.76B | -5.53B | -7.81B | -11.18B | -8.38B | -6.75B | -9.58B | -8.85B |
| Sale/Maturity of Investments | 7.79B | 6.7B | 5.11B | 7.81B | 8.04B | 5.77B | 4.84B | 7.53B | 6.92B |
| Other Investing | 34.13M | -602.64M | 2.84M | -26.52M | -17.98M | -90.17M | 10.94M | -35.31M | 68.9M |
| Cash from Financing | -235.09M | -7.4M | -513.19M | -397.84M | 5.83M | -771.99M | -1.06B | -852.49M | -1.03B |
| Dividends Paid | -188.2M | -254.95M | -308.19M | -84.15M | -355.74M | -235.19M | -501.46M | -531.95M | -700.27M |
| Share Repurchases | -47.81M | -24.75M | -18.23M | -346.36M | -122.43M | -94.14M | -537.16M | -303.65M | -270.22M |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 1000K | 1000K | -1000K | 1000K | 1000K | -1000K | -974K | 1000K | -1000K |
| Other Financing | -6.04M | -17.74M | -21.39M | -56.23M | -45.16M | -12.85M | -22.9M | -19.98M | -53.89M |
| Net Change in Cash | 155.19M▲ 0% | -132.87M▼ 185.6% | 206.11M▲ 255.1% | 1.35B▲ 554.3% | -803.52M▼ 159.6% | -119.5M▲ 85.1% | -86.15M▲ 27.9% | 611.55M▲ 809.9% | 565.19M▼ 7.6% |
| Exchange Rate Effect | 12.85M | -31.42M | 379K | 10.12M | -4.2M | -24.75M | 9.07M | -29.84M | -18.56M |
| Cash at Beginning | 795.28M | 950.47M | 817.6M | 1.02B | 2.37B | 1.57B | 1.45B | 1.36B | 1.97B |
| Cash at End | 950.47M | 817.6M | 1.02B | 2.37B | 1.57B | 1.45B | 1.36B | 1.97B | 2.54B |
| Free Cash Flow | 595.16M▲ 0% | 570.34M▼ 4.2% | 1.08B▲ 89.9% | 1.58B▲ 45.7% | 2.12B▲ 34.1% | 2.52B▲ 18.8% | 2.88B▲ 14.3% | 3.57B▲ 24.2% | 3.47B▼ 2.9% |
| FCF Growth % | -25.38% | -4.17% | 89.95% | 45.71% | 34.14% | 18.82% | 14.32% | 24.22% | -2.89% |
| FCF Margin % | 7.43% | 7.42% | 13.71% | 19.49% | 22.39% | 22.53% | 23.69% | 26.2% | 23.59% |
| FCF per Share | 1.37 | 1.32 | 2.49 | 3.72 | 5.05 | 6 | 7.02 | 8.86 | 8.69 |
WRB Key Ratios
W. R. Berkley Corporation (WRB) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 88.29% | 90.35% | 89.44% | 89.21% | 91.3% | 86.43% | 84.6% | 85.55% | 83.4% | 84.13% |
| Medical Cost Ratio | 81.17% | 79.43% | 82.04% | 81.29% | 83.36% | 78.61% | 78.17% | 77.56% | 77.11% | 80.19% |
| Return on Equity (ROE) | 12.39% | 10.43% | 11.72% | 11.76% | 8.53% | 15.74% | 20.56% | 19.4% | 22.12% | 19.64% |
| Return on Assets (ROA) | 2.67% | 2.3% | 2.6% | 2.65% | 1.92% | 3.37% | 4.19% | 3.89% | 4.52% | 4.2% |
| Equity / Assets | 21.75% | 22.43% | 22.01% | 22.95% | 22.11% | 20.78% | 19.99% | 20.08% | 20.72% | 22.04% |
| Book Value / Share | 11.71 | 12.52 | 12.66 | 14.05 | 14.89 | 15.89 | 16.15 | 18.22 | 20.85 | 24.33 |
| Debt / Equity | 0.49x | 0.46x | 0.51x | 0.43x | 0.43x | 0.49x | 0.42x | 0.38x | 0.34x | 0.29x |
| Revenue Growth | 6.21% | 4.66% | -3.99% | 2.74% | 2.49% | 16.75% | 18.1% | 8.74% | 12.32% | 7.82% |
WRB SEC Filings & Documents
W. R. Berkley Corporation (WRB) SEC filings — annual & quarterly reports (10-K, 10-Q)
WRB Frequently Asked Questions
W. R. Berkley Corporation (WRB) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
W. R. Berkley Corporation (WRB) grew revenue by 7.8% over the past year. This is steady growth.
Yes, W. R. Berkley Corporation (WRB) is profitable, generating $1.78B in net income for fiscal year 2025 (12.1% net margin).
Dividend & Returns
Yes, W. R. Berkley Corporation (WRB) pays a dividend with a yield of 2.64%. This makes it attractive for income-focused investors.
W. R. Berkley Corporation (WRB) has a return on equity (ROE) of 19.6%. This is reasonable for most industries.
Industry Metrics
W. R. Berkley Corporation (WRB) has a combined ratio of 84.1%. A ratio below 100% indicates underwriting profitability.
Explore More WRB
W. R. Berkley Corporation (WRB) financial analysis — history, returns, DCA and operating performance tools
Full WRB Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates